Cargando…

Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series

INTRODUCTION: Serum vitamin D levels measured as 25-hydroxyvitamin D have been shown to be low in cancer patients, including breast cancer patients. However, the vitamin D status has yet to be studied in different breast cancer phenotypes: luminal A, luminal B, HER2+/ER-, and triple negative compris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rainville, Christa, Khan, Yasir, Tisman, Glenn
Formato:	Texto
Lenguaje:	English
Publicado:	Cases Network Ltd 2009
Materias:	Case report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740106/ https://www.ncbi.nlm.nih.gov/pubmed/19830074 http://dx.doi.org/10.4076/1757-1626-2-8390

Ejemplares similares

Coexistence of pernicious anemia and prostate cancer - 'an experiment of nature' involving vitamin B(12 )modulation of prostate cancer growth and metabolism: a case report
por: Tisman, Glenn, et al.
Publicado: (2009)

Pica in iron deficiency: a case series
por: Khan, Yasir, et al.
Publicado: (2010)

Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B(12): a case report
por: Tisman, Glenn, et al.
Publicado: (2011)

Clinical evidence for overcoming capecitabine resistance in a woman with breast cancer terminating in radiologically occult micronodular pseudo-cirrhosis with portal hypertension: a case report
por: Fournier, Christa, et al.
Publicado: (2010)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
por: Vizgan, Niels, et al.
Publicado: (2022)

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
por: Thakkar, A., et al.
Publicado: (2016)

A rare presentation of triple-negative apocrine breast carcinoma with metastases
por: Bedford, Tyler, et al.
Publicado: (2014)

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
por: Mustafi, Sushmita, et al.
Publicado: (2019)

Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review
por: Zubair, Zainab, et al.
Publicado: (2021)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Triple negative invasive lobular carcinoma of the breast presents as small bowel obstruction
por: Khokhlova, Mariya, et al.
Publicado: (2017)

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
por: Dass, Sylvia Annabel, et al.
Publicado: (2021)

Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells
por: Beaudin, Sarah, et al.
Publicado: (2019)

Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer—Implications for Pathogenesis and Therapy
por: Blasiak, Janusz, et al.
Publicado: (2020)

Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy
por: Mustafi, Sushmita, et al.
Publicado: (2021)

Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer
por: Lee, Kevin J, et al.
Publicado: (2021)

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2021)

A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Hua, Xin, et al.
Publicado: (2021)

Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2019)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Comparison of Clinico-Pathological Presentations of Triple-Negative versus Triple-Positive and HER2 Iraqi Breast Cancer Patients
por: Alwan, Nada A. S., et al.
Publicado: (2019)

Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer
por: Zhao, Kangrong, et al.
Publicado: (2021)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Association Between Rheumatoid Arthritis and Serum Vitamin D Levels
por: Sukharani, Naintara, et al.
Publicado: (2021)

Clinical and Cyto-Morphological Characterization of Triple Negative Breast Cancer
por: Kala, Chayanika, et al.
Publicado: (2019)

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients
por: Xu, Qi, et al.
Publicado: (2022)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Targeting a cell state common to triple-negative breast cancers
por: Muellner, Markus K, et al.
Publicado: (2015)

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
por: Raju, Rajesh, et al.
Publicado: (2014)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Roles of long noncoding RNA in triple‐negative breast cancer
por: Das, Plabon Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_92qet4j061hjsg9imlgl8r5emt